Clinical Trial Update: Study of High Dosage CIFN Plus RBV for HCV Genotype 1 Infected Patients Who Are Nonresponders to Prior Therapy [Phase 4]

View source ↗

Summary

Phase 4 study evaluating high-dose interferon alfacon-1 (CIFN) plus ribavirin in Hepatitis C genotype 1 patients who did not respond to prior therapy has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Interferon alfacon-1 (CIFN) (interferon alfacon-1)
• Ribavirin (ribavirin)

Snippet

Sponsor: Beth Israel Medical Center | Conditions: Hepatitis C | Phase 4 | Status: COMPLETED